The future of melanoma detection: Targeted screening, technology and the changing landscape

Hello, this is Danielle Fisher.

Welcome to Melanoma Insights for Professionals, brought to you by Melanoma Institute Australia.

In today's episode, we're exploring the exciting future of melanoma detection and how targeted screening, technology and the changing infrastructure and workforce will transform the way we detect melanoma.

From targeted screening with tailored prevention and advanced imaging to artificial intelligence, we'll explore how these innovations could help us detect melanoma earlier, identify those at greater risk, and make better use of our limited healthcare resources.

Leading our discussion today is dermatologist Professor Pascal Guterra.

Pascal is the director of the Sydney Melanoma Diagnostic Centre at Royal Prince Alfred Hospital, a professorial research fellow at the University of Sydney, and a faculty member of Melanoma Institute Australia.

We're joined in the studio today by Professor Rachel Morton, Director of Health Economics and Health Technology Assessment at Sydney Clinical Trial Centre, the University of Sydney, and a Melanoma Institute Australia faculty member.

We're also delighted to have Professor Victoria Marr and Dr Amelia Smith joining us virtually.

Tori is the Director of the Victorian Melanoma Service at the Alfred and Professor of Dermato-Oncology at the School of Public Health and Preventative Medicine, Monash University.

And we're also joined by Dr Amelia Smit, a Senior Research Fellow in Cancer Epidemiology from the Daffodil Centre, the University of Sydney and Cancer Council New South Wales.

Thank you all for being here today to discuss what advances are being made in melanoma detection and how these technologies and frameworks will transform clinical practice in the future.

Melanoma detection has traditionally relied heavily on the expertise of dermatologists and GPs through clinical examination and dermoscopy.

But the way we detect melanoma is changing rapidly.

Pascal, what do you think melanoma detection will look like in 10 years' time? So

Hello, this is Danielle Fisher.

Welcome to Melanoma Insights for Professionals, brought to you by Melanoma Institute Australia.

In today's episode, we're exploring the exciting future of melanoma detection and how targeted screening, technology and the changing infrastructure and workforce will transform the way we detect melanoma.

From targeted screening with tailored prevention and advanced imaging to artificial intelligence, we'll explore how these innovations could help us detect melanoma earlier, identify those at greater risk, and make better use of our limited healthcare resources.

Leading our discussion today is dermatologist Professor Pascal Guterra.

Pascal is the director of the Sydney Melanoma Diagnostic Centre at Royal Prince Alfred Hospital, a professorial research fellow at the University of Sydney, and a faculty member of Melanoma Institute Australia.

We're joined in the studio today by Professor Rachel Morton, Director of Health Economics and Health Technology Assessment at Sydney Clinical Trial Centre, the University of Sydney, and a Melanoma Institute Australia faculty member.

We're also delighted to have Professor Victoria Marr and Dr Amelia Smith joining us virtually.

Tori is the Director of the Victorian Melanoma Service at the Alfred and Professor of Dermato-Oncology at the School of Public Health and Preventative Medicine, Monash University.

And we're also joined by Dr Amelia Smit, a Senior Research Fellow in Cancer Epidemiology from the Daffodil Centre, the University of Sydney and Cancer Council New South Wales.

Thank you all for being here today to discuss what advances are being made in melanoma detection and how these technologies and frameworks will transform clinical practice in the future.

Melanoma detection has traditionally relied heavily on the expertise of dermatologists and GPs through clinical examination and dermoscopy.

But the way we detect melanoma is changing rapidly.

Pascal, what do you think melanoma detection will look like in 10 years' time? So